Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment

Sergio Cammarata, Roberta Borghi, Luca Giliberto, Matteo Pardini, Valeria Pollero, Cristina Novello, Michele Fornaro, Antonella Vitali, Laura Bracco, Carlo Caltagirone, Paola Bossù, Patrizio Odetti, Massimo Tabaton

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Amnestic mild cognitive impairment (aMCI) is considered a prodromal stage of Alzheimer's disease (AD). We measured plasma levels of amyloid-β-{40} (Aβ-{40}) and Aβ-{42} in 191 subjects with aMCI. Seventy-nine of them were clinically followed for two years. In the total cohort of aMCI cases, the average level of Aβ-{42}, as well as the Aβ-{42}/Aβ-{40} ratio, was significantly higher than those of the 102 cognitively normal age-matched subjects. The aMCI cases that converted to probable AD within 2 years had higher levels of Aβ-{42} and, to a lesser extent, Aβ-{40} than the stable cases. However the large variability of measured values indicates that plasma Aβ is not a suitable marker of incipient AD.

Original languageEnglish
Pages (from-to)267-271
Number of pages5
JournalJournal of Alzheimer's Disease
Volume18
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Amyloid
Alzheimer Disease
Prodromal Symptoms
Cognitive Dysfunction

Keywords

  • Alzheimer's disease
  • Amyloid-β
  • Mild cognitive impairment
  • Plasma

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology
  • Medicine(all)

Cite this

Cammarata, S., Borghi, R., Giliberto, L., Pardini, M., Pollero, V., Novello, C., ... Tabaton, M. (2009). Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment. Journal of Alzheimer's Disease, 18(2), 267-271. https://doi.org/10.3233/JAD-2009-1144

Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment. / Cammarata, Sergio; Borghi, Roberta; Giliberto, Luca; Pardini, Matteo; Pollero, Valeria; Novello, Cristina; Fornaro, Michele; Vitali, Antonella; Bracco, Laura; Caltagirone, Carlo; Bossù, Paola; Odetti, Patrizio; Tabaton, Massimo.

In: Journal of Alzheimer's Disease, Vol. 18, No. 2, 2009, p. 267-271.

Research output: Contribution to journalArticle

Cammarata, S, Borghi, R, Giliberto, L, Pardini, M, Pollero, V, Novello, C, Fornaro, M, Vitali, A, Bracco, L, Caltagirone, C, Bossù, P, Odetti, P & Tabaton, M 2009, 'Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment', Journal of Alzheimer's Disease, vol. 18, no. 2, pp. 267-271. https://doi.org/10.3233/JAD-2009-1144
Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C et al. Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment. Journal of Alzheimer's Disease. 2009;18(2):267-271. https://doi.org/10.3233/JAD-2009-1144
Cammarata, Sergio ; Borghi, Roberta ; Giliberto, Luca ; Pardini, Matteo ; Pollero, Valeria ; Novello, Cristina ; Fornaro, Michele ; Vitali, Antonella ; Bracco, Laura ; Caltagirone, Carlo ; Bossù, Paola ; Odetti, Patrizio ; Tabaton, Massimo. / Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment. In: Journal of Alzheimer's Disease. 2009 ; Vol. 18, No. 2. pp. 267-271.
@article{84f71e92125d48788ccf093185751a6c,
title = "Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment",
abstract = "Amnestic mild cognitive impairment (aMCI) is considered a prodromal stage of Alzheimer's disease (AD). We measured plasma levels of amyloid-β-{40} (Aβ-{40}) and Aβ-{42} in 191 subjects with aMCI. Seventy-nine of them were clinically followed for two years. In the total cohort of aMCI cases, the average level of Aβ-{42}, as well as the Aβ-{42}/Aβ-{40} ratio, was significantly higher than those of the 102 cognitively normal age-matched subjects. The aMCI cases that converted to probable AD within 2 years had higher levels of Aβ-{42} and, to a lesser extent, Aβ-{40} than the stable cases. However the large variability of measured values indicates that plasma Aβ is not a suitable marker of incipient AD.",
keywords = "Alzheimer's disease, Amyloid-β, Mild cognitive impairment, Plasma",
author = "Sergio Cammarata and Roberta Borghi and Luca Giliberto and Matteo Pardini and Valeria Pollero and Cristina Novello and Michele Fornaro and Antonella Vitali and Laura Bracco and Carlo Caltagirone and Paola Boss{\`u} and Patrizio Odetti and Massimo Tabaton",
year = "2009",
doi = "10.3233/JAD-2009-1144",
language = "English",
volume = "18",
pages = "267--271",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Amyloid-β42 plasma levels are elevated in amnestic mild cognitive impairment

AU - Cammarata, Sergio

AU - Borghi, Roberta

AU - Giliberto, Luca

AU - Pardini, Matteo

AU - Pollero, Valeria

AU - Novello, Cristina

AU - Fornaro, Michele

AU - Vitali, Antonella

AU - Bracco, Laura

AU - Caltagirone, Carlo

AU - Bossù, Paola

AU - Odetti, Patrizio

AU - Tabaton, Massimo

PY - 2009

Y1 - 2009

N2 - Amnestic mild cognitive impairment (aMCI) is considered a prodromal stage of Alzheimer's disease (AD). We measured plasma levels of amyloid-β-{40} (Aβ-{40}) and Aβ-{42} in 191 subjects with aMCI. Seventy-nine of them were clinically followed for two years. In the total cohort of aMCI cases, the average level of Aβ-{42}, as well as the Aβ-{42}/Aβ-{40} ratio, was significantly higher than those of the 102 cognitively normal age-matched subjects. The aMCI cases that converted to probable AD within 2 years had higher levels of Aβ-{42} and, to a lesser extent, Aβ-{40} than the stable cases. However the large variability of measured values indicates that plasma Aβ is not a suitable marker of incipient AD.

AB - Amnestic mild cognitive impairment (aMCI) is considered a prodromal stage of Alzheimer's disease (AD). We measured plasma levels of amyloid-β-{40} (Aβ-{40}) and Aβ-{42} in 191 subjects with aMCI. Seventy-nine of them were clinically followed for two years. In the total cohort of aMCI cases, the average level of Aβ-{42}, as well as the Aβ-{42}/Aβ-{40} ratio, was significantly higher than those of the 102 cognitively normal age-matched subjects. The aMCI cases that converted to probable AD within 2 years had higher levels of Aβ-{42} and, to a lesser extent, Aβ-{40} than the stable cases. However the large variability of measured values indicates that plasma Aβ is not a suitable marker of incipient AD.

KW - Alzheimer's disease

KW - Amyloid-β

KW - Mild cognitive impairment

KW - Plasma

UR - http://www.scopus.com/inward/record.url?scp=70350492757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350492757&partnerID=8YFLogxK

U2 - 10.3233/JAD-2009-1144

DO - 10.3233/JAD-2009-1144

M3 - Article

C2 - 19584444

AN - SCOPUS:70350492757

VL - 18

SP - 267

EP - 271

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -